[1]方纬 李剑明.核医学新技术助力心血管疾病的精准诊疗[J].心血管病学进展,2023,(1):1-2.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.001]
　FANG Wei,LI Jianming.Innovative Technology in Nuclear Medicine Optimize Precise Diagnosis and Treatment for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2023,(1):1-2.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.001]
点击复制

核医学新技术助力心血管疾病的精准诊疗()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2023年1期
页码:
1-2
栏目:
述评
出版日期:
2023-01-25

文章信息/Info

Title:
Innovative Technology in Nuclear Medicine Optimize Precise Diagnosis and Treatment for Cardiovascular Disease
作者:
方纬1 李剑明 2
 (1.中国医学科学院阜外医院核医学科,北京 100037;2.泰达国际心血管病医院核医学科,天津 120000)
Author(s):
FANG Wei 1; LI Jianming 2
(1.Department of Nuclear Medicine,Chinese Academy of Medical Sciences & Fuwai Hospital,Beijing 100037,China; 2.Department of Nuclear Medicine,TEDA International Cardiovascular Hospital,Tianjin 120000,China)
关键词:
放射性核素显像; 心血管疾病; 分子影像学
Keywords:
Radionuclide imaging; Cardiovascular disease; Molecular imaging
DOI:
10.16806/j.cnki.issn.1004-3934.2023.01.001
摘要:
放射性核素显像技术在心血管疾病的诊疗过程中发挥重要作用，具有功能影像学的独特优势。随着核素显像新技术的不断发展，定性诊断逐步向定量诊断转变；分子影像学的技术特征使诊断更为特异，应用范围不断拓展；多模态影像技术进一步提高了诊断效能。核素显像技术正在进入创新和发展的全新阶段，将会助力心血管疾病的精准诊疗，使更多的患者受益。
Abstract:
Radionuclide imaging technology plays an important role in the diagnosis and treatment of cardiovascular disease,and has unique advantages in functional imaging. With the continuous development of innovative technology of radionuclide imaging,qualitative diagnosis has gradually changed to quantitative diagnosis. The technical characteristics of molecular imaging make the diagnosis more specific,and its application scope expands continuously . Multimodal imaging technology further improves the diagnostic efficiency. The radionuclide imaging technology is entering a new stage of innovation and development,which will help the precise diagnosis and treatment of cardiovascular disease and benefit more patients.

参考文献/References:

[1].中华医学会核医学分会,中华医学会心血管病学分会. 核素心肌显像临床应用指南（2018）[J]. 中华心血管病杂志,2019,47(7):519-527.
[2].Slomka PJ,Moody JB,Miller RJH,et al. Quantitative clinical nuclear cardiology,part 2:evolving/emerging applications[J]. J Nucl Med,2021,62(2):168-176.
[3].Fang W,Hsu B. Myocardial blood flow quantitation with the SPECT technique:where do we stand?[J]. J Nucl Cardiol,2022,29(2):630-632.
[4].中华医学会心血管病学分会基础研究学组,中华医学会心血管病学分会介入心脏病学组,中华医学会心血管病学分会女性心脏健康学组,等. 冠状动脉微血管疾病诊断和治疗的中国专家共识[J]. 中国循环杂志,2017,32(5):421-430.
[5].Shaw SY. Molecular imaging in cardiovascular disease:targets and opportunities[J]. Nat Rev Cardiol,2009,6(9):569-579.
[6].Stendahl JC,Kwan JM,Pucar D,et al. Radiotracers to address unmet clinical needs in cardiovascular imaging,part 2:inflammation,fibrosis,thrombosis,calcification,and amyloidosis imaging[J]. J Nucl Med,2022,63(7):986-994.
[7].Rischpler C,Siebermair J,Kessler L,et al. Cardiac PET/MRI:current clinical status and future perspectives[J]. Semin Nucl Med,2020,50(3):260-269.

相似文献/References:

[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
　BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
　REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(1):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
　YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(1):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
　ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(1):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
　QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(1):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
　JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(1):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
　HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(1):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[9]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
　Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(1):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[10]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
　WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(1):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]

更新日期/Last Update: 2023-03-10